Anne Steino

Title: Anne Steino: Innovator in Cancer Treatment

Introduction

Anne Steino is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of oncology through her innovative research and development of treatments for malignant gliomas and brain tumors. Her work has the potential to impact the lives of many patients facing these challenging conditions.

Latest Patents

Anne Steino holds a patent for the "Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor." This patent discloses methods and compositions suitable for treating malignancies such as recurrent glioma and progressive secondary brain tumors. The methods employ a hexitol derivative, specifically dianhydrogalactitol, along with its derivatives or analogs, including diacetyldianhydrogalactitol. The compositions can incorporate these hexitol derivatives, showcasing her innovative approach to cancer treatment.

Career Highlights

Throughout her career, Anne has worked with various organizations, including Del Mar Pharmaceuticals Ltd. and Delmar Pharmaceuticals, Inc. Her experience in these companies has allowed her to collaborate with other professionals in the field and contribute to advancements in cancer therapies.

Collaborations

Anne has collaborated with notable colleagues such as Dennis M. Brown and Kent C. Shih. These partnerships have further enriched her research and development efforts, leading to significant advancements in the treatment of brain tumors.

Conclusion

Anne Steino's contributions to cancer treatment through her innovative patent and collaborations highlight her dedication to improving patient outcomes. Her work exemplifies the impact that inventors can have in the medical field, particularly in the fight against malignant gliomas and brain tumors.